IBDEI081 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10554,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,10554,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,10554,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,10555,0)
 ;;=369.04^^72^693^64
 ;;^UTILITY(U,$J,358.3,10555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10555,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10555,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,10555,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,10556,0)
 ;;=369.06^^72^693^77
 ;;^UTILITY(U,$J,358.3,10556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10556,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,10556,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,10556,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,10557,0)
 ;;=369.07^^72^693^76
 ;;^UTILITY(U,$J,358.3,10557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10557,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,10557,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,10557,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,10558,0)
 ;;=369.08^^72^693^91
 ;;^UTILITY(U,$J,358.3,10558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10558,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10558,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,10558,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,10559,0)
 ;;=369.10^^72^693^73
 ;;^UTILITY(U,$J,358.3,10559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10559,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,10559,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,10559,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,10560,0)
 ;;=369.11^^72^693^78
 ;;^UTILITY(U,$J,358.3,10560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10560,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,10560,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,10560,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,10561,0)
 ;;=369.12^^72^693^81
 ;;^UTILITY(U,$J,358.3,10561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10561,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,10561,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,10561,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,10562,0)
 ;;=369.13^^72^693^79
 ;;^UTILITY(U,$J,358.3,10562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10562,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,10562,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,10562,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,10563,0)
 ;;=369.14^^72^693^80
 ;;^UTILITY(U,$J,358.3,10563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10563,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,10563,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,10563,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,10564,0)
 ;;=369.22^^72^693^101
 ;;^UTILITY(U,$J,358.3,10564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10564,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10564,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,10564,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,10565,0)
 ;;=369.60^^72^693^6
 ;;^UTILITY(U,$J,358.3,10565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10565,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,10565,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,10565,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,10566,0)
 ;;=369.9^^72^693^114
 ;;^UTILITY(U,$J,358.3,10566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10566,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,10566,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,10566,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,10567,0)
 ;;=377.61^^72^693^20
 ;;^UTILITY(U,$J,358.3,10567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10567,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,10567,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,10567,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,10568,0)
 ;;=379.02^^72^693^68
 ;;^UTILITY(U,$J,358.3,10568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10568,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,10568,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,10568,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,10569,0)
 ;;=379.07^^72^693^89
 ;;^UTILITY(U,$J,358.3,10569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10569,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,10569,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,10569,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,10570,0)
 ;;=379.92^^72^693^105
 ;;^UTILITY(U,$J,358.3,10570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10570,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,10570,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,10570,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,10571,0)
 ;;=379.93^^72^693^93
 ;;^UTILITY(U,$J,358.3,10571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10571,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,10571,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,10571,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,10572,0)
 ;;=379.99^^72^693^85
 ;;^UTILITY(U,$J,358.3,10572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10572,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,10572,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,10572,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,10573,0)
 ;;=555.9^^72^693^94
 ;;^UTILITY(U,$J,358.3,10573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10573,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,10573,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,10573,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,10574,0)
 ;;=696.1^^72^693^92
 ;;^UTILITY(U,$J,358.3,10574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10574,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,10574,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,10574,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,10575,0)
 ;;=709.2^^72^693^39
 ;;^UTILITY(U,$J,358.3,10575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10575,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,10575,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,10575,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,10576,0)
 ;;=710.0^^72^693^60
 ;;^UTILITY(U,$J,358.3,10576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10576,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,10576,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,10576,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,10577,0)
 ;;=710.9^^72^693^10
 ;;^UTILITY(U,$J,358.3,10577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10577,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,10577,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,10577,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,10578,0)
 ;;=714.0^^72^693^97
 ;;^UTILITY(U,$J,358.3,10578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10578,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,10578,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,10578,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,10579,0)
 ;;=714.30^^72^693^98
 ;;^UTILITY(U,$J,358.3,10579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10579,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,10579,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,10579,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,10580,0)
 ;;=744.89^^72^693^38
 ;;^UTILITY(U,$J,358.3,10580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10580,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,10580,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,10580,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,10581,0)
 ;;=759.6^^72^693^115
 ;;^UTILITY(U,$J,358.3,10581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10581,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,10581,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,10581,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,10582,0)
 ;;=759.82^^72^693^62
 ;;^UTILITY(U,$J,358.3,10582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10582,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,10582,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,10582,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,10583,0)
 ;;=802.4^^72^693^36
 ;;^UTILITY(U,$J,358.3,10583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10583,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,10583,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,10583,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,10584,0)
 ;;=870.1^^72^693^53
 ;;^UTILITY(U,$J,358.3,10584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10584,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,10584,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,10584,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,10585,0)
 ;;=870.2^^72^693^34
 ;;^UTILITY(U,$J,358.3,10585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10585,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,10585,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,10585,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,10586,0)
 ;;=870.3^^72^693^83
 ;;^UTILITY(U,$J,358.3,10586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10586,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,10586,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,10586,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,10587,0)
 ;;=870.9^^72^693^69
 ;;^UTILITY(U,$J,358.3,10587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10587,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,10587,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,10587,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,10588,0)
 ;;=871.0^^72^693^70
 ;;^UTILITY(U,$J,358.3,10588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10588,1,3,0)
 ;;=3^Ocular Laceration
 ;;^UTILITY(U,$J,358.3,10588,1,4,0)
 ;;=4^871.0
 ;;^UTILITY(U,$J,358.3,10588,2)
 ;;=^274886
 ;;^UTILITY(U,$J,358.3,10589,0)
 ;;=871.1^^72^693^71
 ;;^UTILITY(U,$J,358.3,10589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10589,1,3,0)
 ;;=3^Ocular Laceration w/ Prolapse
 ;;^UTILITY(U,$J,358.3,10589,1,4,0)
 ;;=4^871.1
 ;;^UTILITY(U,$J,358.3,10589,2)
 ;;=^274887
 ;;^UTILITY(U,$J,358.3,10590,0)
 ;;=871.2^^72^693^99
 ;;^UTILITY(U,$J,358.3,10590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10590,1,3,0)
 ;;=3^Rupture Eye,Trauma Enuc
 ;;^UTILITY(U,$J,358.3,10590,1,4,0)
 ;;=4^871.2
 ;;^UTILITY(U,$J,358.3,10590,2)
 ;;=^274888
 ;;^UTILITY(U,$J,358.3,10591,0)
 ;;=871.6^^72^693^59
 ;;^UTILITY(U,$J,358.3,10591,1,0)
 ;;=^358.31IA^4^2
